Concentrix (NASDAQ:CNXC) Releases Earnings Results, Misses Estimates By $0.01 EPS

Concentrix (NASDAQ:CNXC) posted its quarterly earnings data on Monday. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01), FiscalAI reports. The company had revenue of $2.46 billion for the quarter, compared to analysts’ expectations of $2.47 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%. Concentrix updated its FY 2026 guidance to 10.830-11.180 EPS and its Q3 2026 guidance to 2.650-2.770 EPS.

Concentrix Trading Up 0.9%

Shares of Concentrix stock traded up $0.23 on Monday, hitting $25.23. The stock had a trading volume of 3,589,207 shares, compared to its average volume of 1,621,175. The stock has a market cap of $1.54 billion, a price-to-earnings ratio of -1.17, a PEG ratio of 0.31 and a beta of 0.43. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.43. The stock’s 50-day simple moving average is $25.93 and its two-hundred day simple moving average is $32.17. Concentrix has a one year low of $22.05 and a one year high of $62.14.

Insider Activity

In related news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the firm’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total value of $133,500,000.00. Following the completion of the sale, the insider owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This trade represents a 68.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Andre S. Valentine acquired 2,500 shares of Concentrix stock in a transaction on Thursday, April 9th. The shares were bought at an average cost of $27.95 per share, for a total transaction of $69,875.00. Following the completion of the transaction, the chief financial officer owned 89,066 shares in the company, valued at approximately $2,489,394.70. This trade represents a 2.89% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.90% of the stock is owned by company insiders.

Institutional Trading of Concentrix

Institutional investors have recently made changes to their positions in the stock. AQR Capital Management LLC grew its holdings in Concentrix by 25.5% in the second quarter. AQR Capital Management LLC now owns 4,305,469 shares of the company’s stock worth $226,252,000 after purchasing an additional 875,556 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Concentrix by 28.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock worth $103,588,000 after buying an additional 551,778 shares in the last quarter. Alyeska Investment Group L.P. purchased a new position in shares of Concentrix in the 4th quarter valued at about $22,913,000. Bank of New York Mellon Corp grew its holdings in Concentrix by 157.1% in the fourth quarter. Bank of New York Mellon Corp now owns 709,770 shares of the company’s stock valued at $29,512,000 after purchasing an additional 433,731 shares during the period. Finally, Marshall Wace LLP increased its position in shares of Concentrix by 1,062.2% in the fourth quarter. Marshall Wace LLP now owns 394,686 shares of the company’s stock valued at $16,411,000 after buying an additional 360,725 shares in the last quarter. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CNXC. Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Canaccord Genuity Group cut their target price on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday, March 25th. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Robert W. Baird dropped their price target on Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a research note on Wednesday, March 25th. Finally, Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Concentrix in a report on Monday, June 22nd. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $44.33.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology?driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back?office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.